Nuclear xenobiotic receptor pregnane X receptor locks corepressor Silencing Mediator for Retinoid and Thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D 3 activation

Yoshihiro Konno, Susumu Kodama, Rick Moore, Nobuhiro Kamiya, Masahiko Negishi

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

We have studied the molecular mechanism by which the nuclear xenobiotic receptors pregnane X receptor (PXR) and constitutive active/androstane receptor (CAR) regulate transcription of the vitamin D 3 24-hydroxylase (CYP24A1) gene. In the absence of vitamin D 3, PXR activates the CYP24A1 gene by directly binding to and transactivating vitamin D-response elements (VDREs) within its promoter. Vitamin D 3 activates the CYP24A1 promoter by dissociating the corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) from the vitamin D receptor (VDR) on those VDREs. PXR strongly represses vitamin D 3 activation of the CYP24A1 gene, in which PXR indirectly binds to and prevents vitamin D 3-dependent dissociation of SMRT from the CYP24A1 promoter. The degree of the PXR-mediated locking of SMRT depends on the relative concentration of vitamin D 3 to the human PXR activator rifampicin; SMRT increased its dissociation as this ratio increased. CAR is also found to prevent dissociation of SMRT from the CYP24A1 promoter. Thus, our present study defines the novel molecular mechanism by which PXR and CAR mediate drug interactions with vitamin D 3 to regulate the CYP24A1 gene. Pxr(+/+) and Pxry(-/-) mice were continuously treated with mouse pXr activator PCN to evaluate the hypothesis that induction of the Cyp24a1 gene is responsible for the loss of bone mineral density often observed in patients treated continuously with PXR-activating drugs. PCN- dependent loss of mineral density is observed in the metaphyseal bones of only the Pxr(+/+) mice. This loss, however, does not correlate with the expression levels of the Cyp24a1 gene in these mice. U.S. Government work not protected by U.S. copyright.

Original languageEnglish
Pages (from-to)265-271
Number of pages7
JournalMolecular Pharmacology
Volume75
Issue number2
DOIs
Publication statusPublished - Feb 2009
Externally publishedYes

Fingerprint

Thyroid Hormone Receptors
Co-Repressor Proteins
Cholecalciferol
Retinoids
Xenobiotics
Cytoplasmic and Nuclear Receptors
Vitamin D Response Element
Pregnenolone Carbonitrile
Genes
Calcitriol Receptors
Vitamin D3 24-Hydroxylase
pregnane X receptor
Rifampin
Drug Interactions
Bone Density
Transcriptional Activation
Minerals
constitutive androstane receptor
Bone and Bones

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Nuclear xenobiotic receptor pregnane X receptor locks corepressor Silencing Mediator for Retinoid and Thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D 3 activation. / Konno, Yoshihiro; Kodama, Susumu; Moore, Rick; Kamiya, Nobuhiro; Negishi, Masahiko.

In: Molecular Pharmacology, Vol. 75, No. 2, 02.2009, p. 265-271.

Research output: Contribution to journalArticle

@article{9b54673acdb44f5bb718bbce75ad6809,
title = "Nuclear xenobiotic receptor pregnane X receptor locks corepressor Silencing Mediator for Retinoid and Thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D 3 activation",
abstract = "We have studied the molecular mechanism by which the nuclear xenobiotic receptors pregnane X receptor (PXR) and constitutive active/androstane receptor (CAR) regulate transcription of the vitamin D 3 24-hydroxylase (CYP24A1) gene. In the absence of vitamin D 3, PXR activates the CYP24A1 gene by directly binding to and transactivating vitamin D-response elements (VDREs) within its promoter. Vitamin D 3 activates the CYP24A1 promoter by dissociating the corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) from the vitamin D receptor (VDR) on those VDREs. PXR strongly represses vitamin D 3 activation of the CYP24A1 gene, in which PXR indirectly binds to and prevents vitamin D 3-dependent dissociation of SMRT from the CYP24A1 promoter. The degree of the PXR-mediated locking of SMRT depends on the relative concentration of vitamin D 3 to the human PXR activator rifampicin; SMRT increased its dissociation as this ratio increased. CAR is also found to prevent dissociation of SMRT from the CYP24A1 promoter. Thus, our present study defines the novel molecular mechanism by which PXR and CAR mediate drug interactions with vitamin D 3 to regulate the CYP24A1 gene. Pxr(+/+) and Pxry(-/-) mice were continuously treated with mouse pXr activator PCN to evaluate the hypothesis that induction of the Cyp24a1 gene is responsible for the loss of bone mineral density often observed in patients treated continuously with PXR-activating drugs. PCN- dependent loss of mineral density is observed in the metaphyseal bones of only the Pxr(+/+) mice. This loss, however, does not correlate with the expression levels of the Cyp24a1 gene in these mice. U.S. Government work not protected by U.S. copyright.",
author = "Yoshihiro Konno and Susumu Kodama and Rick Moore and Nobuhiro Kamiya and Masahiko Negishi",
year = "2009",
month = "2",
doi = "10.1124/mol.108.051904",
language = "English",
volume = "75",
pages = "265--271",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Nuclear xenobiotic receptor pregnane X receptor locks corepressor Silencing Mediator for Retinoid and Thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D 3 activation

AU - Konno, Yoshihiro

AU - Kodama, Susumu

AU - Moore, Rick

AU - Kamiya, Nobuhiro

AU - Negishi, Masahiko

PY - 2009/2

Y1 - 2009/2

N2 - We have studied the molecular mechanism by which the nuclear xenobiotic receptors pregnane X receptor (PXR) and constitutive active/androstane receptor (CAR) regulate transcription of the vitamin D 3 24-hydroxylase (CYP24A1) gene. In the absence of vitamin D 3, PXR activates the CYP24A1 gene by directly binding to and transactivating vitamin D-response elements (VDREs) within its promoter. Vitamin D 3 activates the CYP24A1 promoter by dissociating the corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) from the vitamin D receptor (VDR) on those VDREs. PXR strongly represses vitamin D 3 activation of the CYP24A1 gene, in which PXR indirectly binds to and prevents vitamin D 3-dependent dissociation of SMRT from the CYP24A1 promoter. The degree of the PXR-mediated locking of SMRT depends on the relative concentration of vitamin D 3 to the human PXR activator rifampicin; SMRT increased its dissociation as this ratio increased. CAR is also found to prevent dissociation of SMRT from the CYP24A1 promoter. Thus, our present study defines the novel molecular mechanism by which PXR and CAR mediate drug interactions with vitamin D 3 to regulate the CYP24A1 gene. Pxr(+/+) and Pxry(-/-) mice were continuously treated with mouse pXr activator PCN to evaluate the hypothesis that induction of the Cyp24a1 gene is responsible for the loss of bone mineral density often observed in patients treated continuously with PXR-activating drugs. PCN- dependent loss of mineral density is observed in the metaphyseal bones of only the Pxr(+/+) mice. This loss, however, does not correlate with the expression levels of the Cyp24a1 gene in these mice. U.S. Government work not protected by U.S. copyright.

AB - We have studied the molecular mechanism by which the nuclear xenobiotic receptors pregnane X receptor (PXR) and constitutive active/androstane receptor (CAR) regulate transcription of the vitamin D 3 24-hydroxylase (CYP24A1) gene. In the absence of vitamin D 3, PXR activates the CYP24A1 gene by directly binding to and transactivating vitamin D-response elements (VDREs) within its promoter. Vitamin D 3 activates the CYP24A1 promoter by dissociating the corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) from the vitamin D receptor (VDR) on those VDREs. PXR strongly represses vitamin D 3 activation of the CYP24A1 gene, in which PXR indirectly binds to and prevents vitamin D 3-dependent dissociation of SMRT from the CYP24A1 promoter. The degree of the PXR-mediated locking of SMRT depends on the relative concentration of vitamin D 3 to the human PXR activator rifampicin; SMRT increased its dissociation as this ratio increased. CAR is also found to prevent dissociation of SMRT from the CYP24A1 promoter. Thus, our present study defines the novel molecular mechanism by which PXR and CAR mediate drug interactions with vitamin D 3 to regulate the CYP24A1 gene. Pxr(+/+) and Pxry(-/-) mice were continuously treated with mouse pXr activator PCN to evaluate the hypothesis that induction of the Cyp24a1 gene is responsible for the loss of bone mineral density often observed in patients treated continuously with PXR-activating drugs. PCN- dependent loss of mineral density is observed in the metaphyseal bones of only the Pxr(+/+) mice. This loss, however, does not correlate with the expression levels of the Cyp24a1 gene in these mice. U.S. Government work not protected by U.S. copyright.

UR - http://www.scopus.com/inward/record.url?scp=59449108443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59449108443&partnerID=8YFLogxK

U2 - 10.1124/mol.108.051904

DO - 10.1124/mol.108.051904

M3 - Article

VL - 75

SP - 265

EP - 271

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 2

ER -